Stephen Baxter
Stock Analyst at Wells Fargo
(2.49)
# 2,483
Out of 5,072 analysts
231
Total ratings
45.7%
Success rate
-0.15%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Upgrades: Overweight | $29 → $31 | $28.11 | +10.30% | 3 | Nov 18, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $14 → $11 | $18.16 | -39.43% | 13 | Nov 13, 2025 | |
| CVS CVS Health | Maintains: Overweight | $103 → $102 | $79.86 | +27.72% | 16 | Nov 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $249 → $259 | $244.18 | +6.07% | 16 | Nov 13, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $238 → $252 | $217.42 | +15.90% | 16 | Nov 13, 2025 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $412 → $431 | $514.76 | -16.27% | 17 | Nov 13, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $231 → $165 | $148.33 | +11.24% | 21 | Nov 12, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $41 → $35 | $39.46 | -11.30% | 24 | Nov 12, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $33 → $39 | $36.48 | +6.91% | 7 | Nov 12, 2025 | |
| COR Cencora | Maintains: Overweight | $354 → $405 | $368.53 | +9.90% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $816 → $914 | $883.71 | +3.43% | 9 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.66 | +50.53% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $278.35 | +7.78% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $185 → $221 | $213.14 | +3.69% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $412 → $403 | $338.52 | +19.05% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $267 → $400 | $329.71 | +21.32% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $344 → $347 | $245.99 | +41.06% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2.5 → $3 | $3.45 | -13.04% | 11 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.45 | +101.34% | 3 | Apr 29, 2024 |
The Pennant Group
Nov 18, 2025
Upgrades: Overweight
Price Target: $29 → $31
Current: $28.11
Upside: +10.30%
Oscar Health
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $18.16
Upside: -39.43%
CVS Health
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $79.86
Upside: +27.72%
Universal Health Services
Nov 13, 2025
Maintains: Overweight
Price Target: $249 → $259
Current: $244.18
Upside: +6.07%
Tenet Healthcare
Nov 13, 2025
Maintains: Overweight
Price Target: $238 → $252
Current: $217.42
Upside: +15.90%
HCA Healthcare
Nov 13, 2025
Maintains: Equal-Weight
Price Target: $412 → $431
Current: $514.76
Upside: -16.27%
Molina Healthcare
Nov 12, 2025
Maintains: Overweight
Price Target: $231 → $165
Current: $148.33
Upside: +11.24%
Centene
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $41 → $35
Current: $39.46
Upside: -11.30%
BrightSpring Health Services
Nov 12, 2025
Maintains: Overweight
Price Target: $33 → $39
Current: $36.48
Upside: +6.91%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $354 → $405
Current: $368.53
Upside: +9.90%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $816 → $914
Current: $883.71
Upside: +3.43%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.66
Upside: +50.53%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $278.35
Upside: +7.78%
Nov 5, 2025
Maintains: Overweight
Price Target: $185 → $221
Current: $213.14
Upside: +3.69%
Oct 22, 2025
Maintains: Overweight
Price Target: $412 → $403
Current: $338.52
Upside: +19.05%
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $329.71
Upside: +21.32%
Oct 7, 2025
Maintains: Overweight
Price Target: $344 → $347
Current: $245.99
Upside: +41.06%
Oct 7, 2025
Maintains: Underweight
Price Target: $2.5 → $3
Current: $3.45
Upside: -13.04%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.45
Upside: +101.34%